AGIOS PHARMACEUTICALS, INC. Earnings Per Share, Basic in USD/shares from Q3 2013 to Q3 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Agios Pharmaceuticals, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q3 2013 to Q3 2025.
  • Agios Pharmaceuticals, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2025 was -1.78 USD/shares, a 111% decline year-over-year.
  • Agios Pharmaceuticals, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2025 was -6 USD/shares, a 159% decline year-over-year.
  • Agios Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2024 was 11.9 USD/shares.
  • Agios Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2023 was -6.33 USD/shares, a 49.6% decline from 2022.
  • Agios Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2022 was -4.23 USD/shares, a 116% decline from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)

AGIOS PHARMACEUTICALS, INC. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$6 -$2 -$18 -111% Jul 1, 2025 Sep 30, 2025 10-Q 2025-10-30
Q2 2025 $11.00 -$2 $0 -14.2% Apr 1, 2025 Jun 30, 2025 10-Q 2025-07-31
Q1 2025 $11.00 -$2 $0 -6.9% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-01
Q4 2024 $11.00 -$2 +$0.06 +3.51% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-13
Q3 2024 $11.00 $16.70 +$18.30 Jul 1, 2024 Sep 30, 2024 10-Q 2025-10-30
Q2 2024 -$6 -$2 $0 -11.9% Apr 1, 2024 Jun 30, 2024 10-Q 2025-07-31
Q1 2024 -$6 -$1 +$0.02 +1.36% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-01
Q4 2023 -$6 -$2 -$2 -351% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-13
Q3 2023 -$3 -$2 $0 -10.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q2 2023 -$3 -$2 +$0.17 +10.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 -$3 -$1 +$0.27 +15.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 -$4 $0.68 +$2.42 Oct 1, 2022 Dec 31, 2022 10-K 2025-02-13
Q3 2022 -$6 -$1 +$0.07 +4.49% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 -$6 -$2 $0 -19.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 -$6 -$2 -$29 -106% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $22.00 -$2 $0 -23.4% Oct 1, 2021 Dec 31, 2021 10-K 2022-02-24
Q3 2021 $22.00 -$2 $0 -9.09% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $22.00 -$1 $0 -7.63% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $22.00 $27.00 +$27.50 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$4 -$1 Oct 1, 2020 Dec 31, 2020 10-K 2022-02-24
Q3 2020 -$1 Jul 1, 2020 Sep 30, 2020 10-K 2022-02-24
Q2 2020 -$1 Apr 1, 2020 Jun 30, 2020 10-K 2022-02-24
Q1 2020 -$1 Jan 1, 2020 Mar 31, 2020 10-K 2022-02-24
Q3 2015 -$1 -$1 -1073% Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-06
Q4 2014 -$1 -$1 Oct 1, 2014 Dec 31, 2014 10-K 2016-02-26
Q3 2014 $0.11 +$0.63 Jul 1, 2014 Sep 30, 2014 10-K 2016-02-26
Q2 2014 -$1 Apr 1, 2014 Jun 30, 2014 10-K 2016-02-26
Q1 2014 $0 Jan 1, 2014 Mar 31, 2014 10-K 2016-02-26
Q3 2013 -$1 Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07

AGIOS PHARMACEUTICALS, INC. Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $11.90 +$18.20 Jan 1, 2024 Dec 31, 2024 10-K 2025-02-13
2023 -$6 -$2 -49.6% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-13
2022 -$4 -$31 -116% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-13
2021 $26.60 +$31.30 Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
2020 -$5 +$2.12 +30.9% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 -$7 Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.